Overview
Evidence-based recommendations on multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis.
Last reviewed: 21 June 2017
This guidance replaces the NICE medtech innovation briefing on The BCM – Body Composition Monitor for managing fluid in people having dialysis (MIB41).
Diagnostics guidance 29 has been migrated to HealthTech guidance 441.
Next review: This guidance will be reviewed if there is new evidence that is likely to affect the recommendations.